论文信息 - Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3 - 字舞流文

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

P. O'Connor | M. McTigue | S. Yamazaki | H. Zou | S. Bender | R. Kania | D. Hu-Lowe | D. Shalinsky | Jeffrey H. Chen | G. Wickman | E. Wu | K. Amundson | B. Murray | M. Hallin | D. Rewolinski | M. Grazzini | Hu-Lowe D Dana